1. Genetic counselling, BRCA1/2 status and clinico-pathologic characteristics of patients with ovarian cancer before 50 years of ageMirjam Cvelbar, Marko Hočevar, Srdjan Novaković, Vida Stegel, Andraž Perhavec, Mateja Krajc, 2017, original scientific article Abstract: In Slovenia like in other countries, till recently, personal history of epithelial ovarian cancer (EOC) has not been included among indications for genetic counselling. Recent studies reported up to 17% rate of germinal BRCA1/2 mutation (gBRCA1/2m) within the age group under 50 years at diagnosis. The original aim of this study was to invite to the genetic counselling still living patients with EOC under 45 years, to offer gBRCA1/2m testing and to perform analysis of gBRCA1/2m rate and of clinico-pathologic characteristics. Later, we added also the data of previously genetically tested patients with EOC aged 45 to 49 years. Patients and methods. All clinical data have to be interpreted in the light of many changes happened in the field of EOC just in the last few years: new hystology stage classification (FIGO), new hystology types and differentiation grades classification, new therapeutic possibilities (PARP inhibitors available, also in Slovenia) and new guidelines for genetic counselling of EOC patients (National Comprehensive Cancer Network, NCCN), together with next-generation sequencing possibilities. Results. Compliance rate at the invitation was 43.1%. In the group of 27 invited or previously tested patients with EOC diagnosed before the age of 45 years, five gBRCA1/2 mutations were found. The gBRCA1/2m detection rate within the group was 18.5%. There were 4 gBRCA1 and 1 gBRCA2 mutations detected. In the extended group of 42 tested patients with EOC diagnosed before the age of 50 years, 14 gBRCA1/2 mutations were found. The gBRCA1/2m detection rate within this extended, partially selected group was 33.3%. There were 11 gBRCA1 and 3 gBRCA2 mutations detected. Conclusions. The rate of gBRCA1/2 mutation in tested unselected EOC patients under the age of 50 years was higher than 10%, namely 18.5%. Considering also a direct therapeuthic benefit of PARP inhibitors for BRCA positive patients, there is a double reason to offer genetic testing to all EOC patients younger than 50 years. Regarding clinical data, it is important to perform their re-interpretation in everyday clinical practice, because this may influence therapeutic possibilities to be offered.
Keywords: ovarian cancer, BRCA 1/2, genetic counseling
Published in DiRROS: 24.05.2024; Views: 85; Downloads: 32
 Full text (513,68 KB) |
2. Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancerTanja Marinko, Jure Dolenc, Cvetka Bilban-Jakopin, 2014, original scientific article Abstract: Background. Trastuzumab therapy given in combination with one of several chemotherapy regimens is currently considered the standard of care for the treatment of early-stage, human epidermal growth factor receptor-2 (HER2) -positive breast cancer. The treatment with trastuzumab is due to a significant impact on the survival part of the standard adjuvant treatment of patients with HER2-positive breast cancer. Patients treated with postoperative breast or chest wall irradiation receive trastuzumab concomitant with radiotherapy. In a small proportion of patients trastuzumab causes cardiotoxicity. Preclinical findings indicate a radiosensibilizing effect of trastuzumab in breast cancer cells, but it is not yet clear whether it radiosensibilizes cells of healthy tissues too.Conclusions. Special attention is required when left breast or left thoracic wall is irradiated in patient receiving trastuzumab, because long-term effects of the concurrent treatment with trastuzumab and radiotherapy are not yet known. In an era where more patients are surviving a diagnosis of breast cancer, better understanding and earlier detection of therapy-induced cardiac toxicity will be of paramount importance.
Keywords: radiotherapy, cardiotoxicity, trastuzumab, early breast cancer
Published in DiRROS: 11.04.2024; Views: 141; Downloads: 65
Full text (817,95 KB)
This document has many files! More... |
3. |
4. Hydrothermal synthesis of rare-earth modified titania : influence on phase composition, optical properties, and photocatalytic activityNejc Rozman, David Maria Tobaldi, Uroš Cvelbar, Harinarayanan Puliyalil, Joao Antonio Labrincha, Andraž Legat, Andrijana Sever Škapin, 2019, original scientific article Abstract: In order to expand the use of titania indoor as well as to increase its overall performance, narrowing the band gap is one of the possibilities to achieve this. Modifying with rare earths (REs) has been relatively unexplored, especially the modification of rutile with rare earth cations. The aim of this study was to find the influence of the modification of TiO2 with rare earths on its structural, optical, morphological, and photocatalytic properties. Titania was synthesized using TiOSO4 as the source of titanium via hydrothermal synthesis procedure at low temperature (200 °C) and modified with selected rare earth elements, namely, Ce, La, and Gd. Structural properties of samples were determined by X-ray powder diffraction (XRD), and the phase ratio was calculated using the Rietveld method. Optical properties were analyzed by ultraviolet and visible light (UV-Vis) spectroscopy. Field emission scanning electron microscope (FE-SEM) was used to determine the morphological properties of samples and to estimate the size of primary crystals. X-ray photoelectron spectroscopy (XPS) was used to determine the chemical bonding properties of samples. Photocatalytic activity of the prepared photocatalysts as well as the titania available on the market (P25) was measured in three different setups, assessing volatile organic compound (VOC) degradation, NOx abatement, and water purification. It was found out that modification with rare earth elements slows down the transformation of anatase and brookite to rutile. Whereas the unmodified sample was composed of only rutile, La- and Gd-modified samples contained anatase and rutile, and Ce-modified samples consisted of anatase, brookite, and rutile. Modification with rare earth metals has turned out to be detrimental to photocatalytic activity. In all cases, pure TiO2 outperformed the modified samples. Cerium-modified TiO2 was the least active sample, despite having a light absorption tail up to 585 nm wavelength. La- and Gd-modified samples did not show a significant shift in light absorption when compared to the pure TiO2 sample. The reason for the lower activity of modified samples was attributed to a greater Ti3+/Ti4+ ratio and a large amount of hydroxyl oxygen found in pure TiO2. All the modified samples had a smaller Ti3+/Ti4+ ratio and less hydroxyl oxygen
Keywords: TiO2, photocatalytic activity, rare earths, modification, visible light activity
Published in DiRROS: 22.11.2023; Views: 331; Downloads: 157
Full text (2,40 MB)
This document has many files! More... |
5. Effect of belowground deployment of entomopathogenic fungus Metarhizium brunneum on strawberry plants and aboveground pestsJaka Razinger, Darinka Koron, Špela Modic, Eva Praprotnik, Primož Žigon, Uroš Žibrat, Matej Knapič, Janez Lapajne, Andrej Vončina, Lovro Sinkovič, Nika Cvelbar Weber, 2023, other scientific articles Keywords: biological control, integrated pest management, agricultural entomology, entomopathogenic fungi, hyperspectral imaging, remote sensing, plant-microbe-pest interaction, plant physiology, rhizosphere competence
Published in DiRROS: 27.07.2023; Views: 344; Downloads: 0 |
6. Dinamika dolžine telomerov v levkocitih po zdravljenju z obsevanjem pri raku dojkTanja Marinko, Sara Redenšek Trampuž, Ana Trstenjak, Vita Dolžan, Katarina Trebušak Podkrajšek, Katja Goričar, 2023, published scientific conference contribution Abstract: Obsevanje je del standardnega zdravljenja bolnic z rakom dojk. Odgovor na zdravljenje z obsevanjem je pri vsakem posamezniku drugačen in je odvisen tudi od genetskih dejavnikov. Eden od novejših genetskih označevalcev odgovora na obsevanje je dolžina telomerov. Telomeri ščitijo kromosome pred krajšanjem in vzdržujejo genomsko stabilnost. Rezultati naše raziskave kažejo, da se dinamika spreminjanja dolžine telomerov takoj po zdravljenju z obsevanjem in v šestih mesecih po obsevanju pri bolnicah z neinvazivnim rakom dojk spreminja in bi lahko služila kot biološki označevalec odgovora na obsevanje. Molekularni mehanizmi, povezani s tem procesom, ostajajo zaenkrat večinoma neraziskani.
Keywords: rak dojk, obsevanje, onkološko zdravljenje
Published in DiRROS: 16.06.2023; Views: 371; Downloads: 142
Full text (1,78 MB)
This document has many files! More... |
7. |
8. |
9. |
10. Dopolnilno obsevanje po ohranitveni operaciji raka dojk s sočasnim dodatkom doze na ležišče tumorja : izidi zdravljenjaMitja Anžič, Jasenka Gugić Kevo, Andreja Gojkovič Horvat, Danijela Golo, Maja Ivanetič Pantar, Tanja Marinko, Marija Snežna Paulin-Košir, Ivica Ratoša, 2022, published professional conference contribution abstract Keywords: onkologija, rak dojke, kemoterapija
Published in DiRROS: 27.01.2023; Views: 437; Downloads: 109
Full text (45,74 KB) |
